←
National Cancer Institute25,437 posts
National Cancer Institute avatar✓

National Cancer Institute ✓

@theNCI

The U.S. government’s agency for cancer research. Part of @NIH. Engagement ≠ endorsement. Questions about cancer? Reach us here: cancer.gov/contact

◷ Joined May 2009▧ 11,292 Photos and videos
Dr. Anthony Letai avatar
⟳ National Cancer Institute retweeted
Dr. Anthony Letai@NCIDirector·Oct 20

If your Author Accepted Manuscript was supported by @NIH funding, it must be posted publicly to PMC without an embargo. There's no cost and it does not require buying expensive open access plans. Take steps to upload your Author Accepted Manuscript here: nihms.nih.gov/login/?next=/s…

National Cancer Institute avatar
National Cancer Institute@theNCI·Nov 16

JOB OPENING: Deputy Director, Center for Global Health. This position provides executive leadership for NCI's global research portfolio, including advancing research capacity, implementation science, and cancer control. Apply by November 18 go.nih.gov/cNiumsg

Post attachment
National Cancer Institute avatar
National Cancer Institute@theNCI·Nov 12

NCI researchers have studied the relationship between rheumatoid arthritis (RA) and hormone receptor-positive (HR+) breast cancer. Patients with RA had a 20% lower risk of HR+ breast cancer, and patients with HR+ breast cancer had a 7% lower chance of later developing RA. Read the study: doi.org/10.1093/jnci/djag387

Post attachment
National Cancer Institute avatar
National Cancer Institute@theNCI·Nov 11

More men with low-risk prostate cancer are holding off on radiation or surgery, a new study found. In NCI cancer registry data, 83.4% received neither treatment within a year of diagnosis in 2023, up from 33.6% in 2010. The findings suggest progress toward avoiding unnecessary treatment. Read the study: doi.org/10.1002/cncr.70603

Post attachment
National Cancer Institute avatar
National Cancer Institute@theNCI·Nov 9

Our Patient-Derived Models Repository (NCI-PDMR) has released its first publicly available tissue microarray panel from pancreatic adenocarcinoma patient-derived xenografts, allowing researchers to screen protein biomarkers across 60 tumor models. go.nih.gov/L4yPEVJ

Post attachment
National Cancer Institute avatar
National Cancer Institute@theNCI·Nov 6

Meet Bart Vanhaesebroeck, whose REWIRE-CAN team is exploring whether pushing cancer’s growth signals beyond their tolerated limits could make colorectal cancer cells vulnerable. Watch what motivates his work. go.nih.gov/3G8zV4V @CancerGrand

0:37
National Cancer Institute avatar
National Cancer Institute@theNCI·Nov 4

A natural RNA modification could help synthetic mRNA make proteins more efficiently and accurately. NCI-led research in cells and mice points to possibilities for future mRNA vaccines and therapies. Explore the findings: go.nih.gov/fwpmhRw

Post attachment
National Cancer Institute avatar
National Cancer Institute@theNCI·Nov 2

For Paula, being able to enjoy everyday moments with her family meant so much. Taking her newborn for a walk. Sitting around the dinner table with family. Being present in her own life. Her experience offers a personal perspective on an important focus of cancer research: quality of life. Watch her reflect on daily life while participating in a clinical trial.

0:48
National Cancer Institute avatar
National Cancer Institute@theNCI·Oct 30

Understanding cancer risk means looking beyond genetics alone. Exposome research helps us measure how environmental factors—from air quality to diet to stress—shape health across a lifetime, creating new opportunities for prevention. go.nih.gov/aTtmsGu @NIH

National Cancer Institute avatar
National Cancer Institute@theNCI·Oct 29

NCI researchers uncovered why a widely used #leukemia drug can cause movement and balance problems in some patients. Understanding treatment-related side effects is essential to improving cancer care, quality of life, and outcomes for patients. go.nih.gov/wWjR0JP

Post attachment
National Cancer Institute avatar
National Cancer Institute@theNCI·Oct 28

Understanding how cells can heritably reprogram gene expression without mutating their DNA may open new strategies to prevent tumor cells from acquiring resistance to therapy. See our most recent research on treatment resistance: go.nih.gov/qw3WugR

Post attachment
National Cancer Institute avatar
National Cancer Institute@theNCI·Oct 27

Menopausal hormone therapy does not raise the risk of developing or dying from liver cancer, according to results from two randomized trials that followed more than 27,000 postmenopausal women for nearly 24 years. The findings are from @NIH Women’s Health Initiative. Read more: go.nih.gov/l1ycc0C

Post attachment